| Ytd | -83.36% | |
| 1y | -90.41% |
| Open | 0.23 | Prev Close | 0.17 | Low | 0.15 | High | 0.24 | Mkt Cap | 6.17M |
| Vol | 352.27M | Avg Vol | 12.87M | EPS | -0.27 | P/E | -0.63 | Forward P/E | N/A |
| Beta | 1.73 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 0.24 | 200-d Avg | 0.72 | 1yr Est | 30.00 |
Gainers Jupiter Neurosciences (NASDAQ:JUNS) stock rose 36.4% to $0.23 during Tuesday's pre-mark
Transaction expands Jupiter into a dual clinical-stage CNS company by adding a differentiated FDA-de
Gainers Universe Pharmaceuticals (NASDAQ:UPC) stock moved upwards by 284.8% to $11.39 during Monday
Gainers Universe Pharmaceuticals (NASDAQ:UPC) stock moved upwards by 159.6% to $7.68 during Monday&
Universe Pharmaceuticals Inc (NASDAQ: UPC) surged 228.4% to $9.72 in pre-market trading after announ
Gainers Universe Pharmaceuticals (NASDAQ:UPC) stock moved upwards by 168.2% to $7.94 during Friday&
T TO COMPLETION, DATED JUNE 26, 2026 Jupiter Neurosciences, Inc. 16,000,000 Shares of Common Stock
Shares of elf Beauty Inc (NYSE: ELF) rose sharply in pre-market trading after beating analyst expect